CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 24 filers reported holding CYCLO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,349 | -30.6% | 4,999 | -24.1% | 0.00% | – |
| Q1 2024 | $9,149 | -2.0% | 6,582 | +12.1% | 0.00% | – |
| Q4 2023 | $9,335 | -2.9% | 5,871 | -13.2% | 0.00% | – |
| Q3 2023 | $9,609 | -15.3% | 6,767 | -5.2% | 0.00% | – |
| Q2 2023 | $11,348 | +113380.0% | 7,137 | -40.3% | 0.00% | – |
| Q1 2023 | $10 | +42.9% | 11,953 | +149.8% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 4,785 | +4.5% | 0.00% | – |
| Q3 2022 | $9,000 | +125.0% | 4,580 | +101.8% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 2,270 | +50.5% | 0.00% | – |
| Q1 2022 | $5,000 | +66.7% | 1,508 | +124.4% | 0.00% | – |
| Q4 2021 | $3,000 | -62.5% | 672 | -41.8% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 1,154 | +104.2% | 0.00% | – |
| Q2 2021 | $6,000 | +200.0% | 565 | +191.2% | 0.00% | – |
| Q1 2021 | $2,000 | – | 194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 260,377 | $413,999 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,348 | $3,733 | 0.00% |
| NORTHERN TRUST CORP | 16,593 | $26,383 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| IFP Advisors, Inc | 26 | $76 | 0.00% |
| OSAIC HOLDINGS, INC. | 4,600 | $7,314 | 0.00% |
| Princeton Global Asset Management LLC | 300 | $477 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 100,388 | $159,616 | 0.00% |
| BlackRock Inc. | 362 | $576 | 0.00% |
| Citadel Advisors | 16,979 | $26,997 | 0.00% |